Dermovate Scalp Application

Dermovate Scalp Application is a medicine authorised by Swissmedic under authorisation number 41823. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 23 February 1979 and the authorisation is valid without a time limit. ATC code D07AD01 places the medicine in the group Corticosteroids, dermatological preparations.

Dispensing category B
Authorisation number 41823
ATC D07AD01
Synthetic medicines

Authorisation data
Authorisation number	41823
Name	Dermovate Scalp Application
Full name	Dermovate Scalp Application, Lösung
Authorisation holder	GlaxoSmithKline AG
Medicinal product code	Synthetic medicines
Dispensing category	B · Prescription only
ATC code	D07AD01
First authorisation	23 February 1979
Authorisation validity	unlimited

Strengths
No.	Name	Dispensing category	Authorisation date
1	Dermovate Scalp Application, Lösung	B	23 February 1979

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
11	25	ml	D07AD01	10.05.1.	B
38	100	ml	D07AD01	10.05.1.	B

Scroll the table sideways

Medicines in the same ATC group

ClareluxAuthorisation number 60393 · Pierre Fabre Pharma SA · ATC D07AD01B Clobetasol LemanAuthorisation number 70125 · Leman SKL SA · ATC D07AD01B Clobetasol Leman 0.5mg/gAuthorisation number 68438 · Leman SKL SA · ATC D07AD01B ClobexAuthorisation number 57650 · Galderma SA · ATC D07AD01B DermovateAuthorisation number 39905 · GlaxoSmithKline AG · ATC D07AD01B DermovateAuthorisation number 39906 · GlaxoSmithKline AG · ATC D07AD01B

Other medicines from this authorisation holder

AREXVYAuthorisation number 69310 · ATC J07BX05B Adartrel 0Authorisation number 56907 · ATC N04BC04B Anoro Ellipta 55 mcg/22 mcgAuthorisation number 63152 · ATC R03AL03B Arnuity Ellipta 90 mcgAuthorisation number 65707 · ATC R03BA09B Augmentin 1 g (875/125)Authorisation number 53692 · ATC J01CR02A Augmentin 625 mg (500/125)Authorisation number 45674 · ATC J01CR02A Augmentin Duo 457 mg (400/57)Authorisation number 53974A AvamysAuthorisation number 57968 · ATC R01AD12B

Frequently asked questions

Is Dermovate Scalp Application authorised in Switzerland?

Yes. Dermovate Scalp Application is authorised by Swissmedic under authorisation number 41823, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Dermovate Scalp Application have?

Dermovate Scalp Application is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Dermovate Scalp Application?

The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.